Innovation: Individualized Cancer Treatment
Avera’s work to personalize cancer treatment could help people around the world. Leaders for the health system made the announcement Tuesday that the genomic oncology team is joining with the Worldwide Innovative Networking Consortium to participate in research and clinical trials. Now internationally renowned cancer expert Doctor Brian Leyland-Jones and Avera’s Center for Precision Oncology Director Casey Williams talk about the potential that exists in the new partnership. They explain the future of cancer treatment, the challenges that come with a shift in health protocols, and the patient response to using genomics to target tumors as individual threats.